Physician profile
Christopher D Fahey
NPI 1780885384
$2,054.16
in general payments reported to CMS, 2019-2025
21 companies · $582 in 2025
The $582 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.55 · 2021: $86.93 · 2022: $166 · 2023: $632 · 2024: $556 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,679 · Education: $90.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,679.42 |
| Education | $90.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $734.45 | 2023-2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $200.96 | 2021-2023 | |
| Lilly USA, LLC | $189.97 | 2022-2023 | Emgality, Amyvid, Reyvow |
| Jazz Pharmaceuticals INC. | $152.24 | 2024-2025 | |
| Pfizer INC. | $149.07 | 2023 | |
| Axsome Therapeutics, INC. | $145.57 | 2024 | Sunosi |
| Avadel Cns Pharmaceuticals, LLC | $88.25 | 2024-2025 | Lumryz |
| Corium, LLC | $49.99 | 2022-2023 | Adlarity |
| Abbott Laboratories | $49.44 | 2022-2023 | Infinity |
| Amgen INC. | $49.28 | 2021-2023 | Aimovig |
| Biogen, INC. | $37.13 | 2023 | Tysabri, Vumerity |
| Ge Healthcare | $29.54 | 2022 | |
| Abbvie INC. | $25.30 | 2023 | |
| Sanofi-Aventis U.S. LLC | $23.79 | 2023 | |
| Noctrix Health, INC. | $22.92 | 2025 | Nidra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $21.74 | 2023 | Inpefa |
| Merck Sharp & Dohme LLC | $19.84 | 2023 | Verquvo, Belsomra, Steglatro |
| Genentech USA, INC. | $19.78 | 2020 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.43 | 2022 | |
| Fisher & Paykel Healthcare INC | $14.70 | 2025 | Fisher & Paykel Healthcare |
| Teva Pharmaceuticals USA, INC. | $11.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Fahey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.